ArticleThe World Allergy Organization journal2024

Different doses and courses of omalizumab for patients with chronic spontaneous urticaria: A systematic review with meta-analysis and trial sequential analysis.

Haiyan Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.